Rapid Prediction of Individual Dosage Requirements for Lignocaine

[1]  F. Follath,et al.  Experience with NONMEM: analysis of serum concentration data in patients treated with mexiletine and lidocaine. , 1984, Drug metabolism reviews.

[2]  A W Kelman,et al.  Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring. , 1983, Therapeutic drug monitoring.

[3]  A. Atkinson,et al.  Excessive serum lidocaine levels during maintenance infusions: mechanisms and prevention. , 1982, American Heart Journal.

[4]  F. Follath,et al.  [Slower lidocaine elimination and dose adjustment in patients with heart failure]. , 1982, Schweizerische medizinische Wochenschrift.

[5]  J. P. Shea,et al.  Influence of long‐term infusions on lidocaine kinetics , 1982, Clinical pharmacology and therapy.

[6]  G. Wagner,et al.  On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. , 1982, British journal of clinical pharmacology.

[7]  F. Follath,et al.  Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline. , 1982, American Review of Respiratory Disease.

[8]  G. Wagner,et al.  Control of lidocaine therapy: new perspectives. , 1982, Therapeutic drug monitoring.

[9]  H D Hill,et al.  Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination. , 1981, Clinical chemistry.

[10]  J. Lima,et al.  A comparison of methods of lidocaine administration in patients , 1981, Clinical pharmacology and therapeutics.

[11]  M. Crawford,et al.  Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations. , 1981 .

[12]  G. Tucker,et al.  Lignocaine and indocyanine green kinetics in patients following myocardial infarction. , 1980, British journal of clinical pharmacology.

[13]  L. Haywood,et al.  Lidocaine efficacy and toxicity assessed by a new, rapid method , 1980, Clinical pharmacology and therapeutics.

[14]  L B Sheiner,et al.  Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.

[15]  P. R. Reid,et al.  Lidocaine kinetics predicted by indocyanine green clearance. , 1978, The New England journal of medicine.

[16]  R. Woosley,et al.  Pharmacokinetics of antiarrhythmic drugs. , 1978, The American journal of cardiology.

[17]  Y. Latour,et al.  Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. , 1977, Annals of internal medicine.

[18]  P. R. Reid,et al.  Variability of early lidocaine levels in patients. , 1977, American heart journal.

[19]  R. Nation,et al.  Lignocaine kinetics in cardiac patients and aged subjects. , 1977, British journal of clinical pharmacology.

[20]  P. Poole‐Wilson,et al.  Logical approach to lignocaine therapy. , 1976, British medical journal.

[21]  L B Sheiner,et al.  Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations. , 1975, Annals of internal medicine.

[22]  H. Wellens,et al.  Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. , 1974, The New England journal of medicine.

[23]  L. Sheiner,et al.  Modelling of individual pharmacokinetics for computer-aided drug dosage. , 1972, Computers and biomedical research, an international journal.

[24]  A. Jazwinski.  Stochastic Processes and Filtering Theory , 1970 .

[25]  D C Harrison,et al.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. , 1967, The New England journal of medicine.